Medindia LOGIN REGISTER
Medindia
Advertisement

ChineseInvestors.com, Inc. to Present at the Disruptive Growth & Healthcare Conference in NYC on February 16, 2017

Wednesday, February 15, 2017 General News
Advertisement
NEW YORK, February 15, 2017 /PRNewswire/ --
Advertisement

ChineseInvestors.com (OTCQB: CIIX) (the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, today announced its management team will be presenting at the 2017 Disruptive Growth & Healthcare Conference in New York City, February 15th and 16th. The conference location is 730 Third Ave. New York, NY.  The Company presents at 9 AM on February 16th and will be holding one-on-one meetings both days.
Advertisement

WallStreet Research™ will also be running one-on-one meetings with investors on February 17th, at the Penn Club of New York, on 30 W 44th Street, NYC.

Copies of the Company's materials, are available at the CIIX website http://www.ChineseInvestors.com . The WallStreet Research™ Corporate Profile is available at http://www.WallStreetResearch.org.

About ChineseInvestors.com  

ChineseInvestors.com, Inc., (OTCQB: CIIX), headquartered in Los Angeles, with offices in New York City and Shanghai China, is a Company that engages in providing a wide range of products, services, and information for the global Chinese speaking population. Founded in 1999, CIIX endeavors to be an innovative company providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to various partners; (c) consultative services to smaller private companies considering becoming a public company; (d) advertising and public relation related support services; and (e) other services we may identify having the potential to create value or partnership opportunity with our existing services.  http://www.Chinesefn.com.  

The Company is now beginning to change its focus of solely being a premier Internet information provider by expanding into retail and online sales of CBD products via its new website: http://www.ChineseCBDoil.com.  

Information on CIIX can be found at http://www.ChineseInvestors.com.    

About WallStreet Research™ 

WallStreet Research™ ("WSR") is a prominent research boutique led by Mr. Alan Stone, Managing Director of Alan Stone & Company, LLC (ASC). The firm specializes in the microcap and small cap investment arena, looking for emerging growth companies with strong management, unique or proprietary technology, significant market potential, financial strength, and outstanding long-term earnings growth possibilities.  WallStreet Research is ranked Number One on the Google, Yahoo and Bing Search engines. Information on WallStreet Research can be found at http://www.WallStreetResearch.org

About The Disruptive Growth & Healthcare Conference 

The Conference represents an opportunity to bring together emerging companies and investment firms working in the healthcare industry.  The Conference focuses on mostly NYSE, NASDAQ, and OTCQB publicly traded companies.  The 2017 Disruptive Growth & Healthcare Conference will offer investors an opportunity to discover life science companies focusing on solutions to unmet medical needs, and growth companies with disruptive technologies and business models.

Contact / Source: ChineseInvestors.com Inc.? Warren Wang, CEO? 14 Wall Street, 20th Floor ?New York, NY 10005? Email: [email protected] http://www.Chinesefn.com http://www.ChineseCBDoil.com  ? Alan Klitenic, Director of Investor Relations [email protected] +1-(214)636-2548 WallStreet Research™ Alan Stone, +1-310-444-3940 [email protected] Barbara Blake, +1-415-419-4239 [email protected] http://www.WallStreetResearch.org http://www.SouthFloridaInvestmentForum.com http://www.SouthernCaliforniaInvestmentForum.com http://www.SmallCapConference.org

SOURCE ChineseInvestors.com

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close